Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Preferred stock	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Non-controlling Interest -
Beginning balance at Dec. 31, 2020	$ 622,948		$ 406,665	$ 9	$ 853,824		$ 0	$ (626,456)		$ 0	$ (11,094)
Preferred stock, beginning balance (in shares) at Dec. 31, 2020			23,219,613
Common stock, beginning balance (in shares) at Dec. 31, 2020				92,490,768
Treasury stock, beginning balance (in shares) at Dec. 31, 2020							(800,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Series AA Preferred Stock (in shares)			23,219,613	46,439,226
Conversion of Series AA Preferred Stock	0		$ (406,665)	$ 5	406,660
Exercise of stock options	3,013				3,013
Exercise of stock options (in shares)				2,203,381
Issuance of common stock in connection with Molotov acquisition	98,791			$ 1	98,790
Issuance of common stock in connection with Molotov acquisition (in shares)				5,690,669
Issuance of common stock in connection with Edisn acquisition	8,262				8,262
Issuance of common stock in connection with Edisn acquisition (in shares)				287,768
Issuance of common stock/At-the-market offering, net of offering costs	140,395			$ 1	140,394
Issuance of common stock/At-the-market offering, net of offering costs (in shares)				5,338,607
Exercise of warrants	19,991				19,991
Exercise of warrants (in shares)				1,598,234
Issuance of treasury stock in connection with acquisitions	8,538				8,538
Issuance of treasury stock in connection with acquisitions (in shares)							800,000
Recognition of debt discount on 2026 Convertible Notes	87,946				87,946
Delivery of common stock underlying restricted stock units (in shares)				91,580
Shares repurchased in connection with separation agreement	0
Shares repurchased in connection with separation agreement (in shares)				(166,599)
Stock-based compensation	63,796				63,796
Foreign currency translation adjustment	172				0					172
Other	(8)				(8)
Other (in shares)				(22,739)
Net loss	(382,963)				0			(382,837)			(126)
Net loss attributable to non-controlling interest	126
Ending balance at Dec. 31, 2021	$ 670,881	$ (75,264)	$ 0	$ 16	1,691,206	$ (87,946)	$ 0	(1,009,293)	$ 12,682	172	(11,220)
Treasury stock, ending balance (in shares) at Dec. 31, 2021							0
Preferred stock, ending balance (in shares) at Dec. 31, 2021			0
Common stock, ending balance (in shares) at Dec. 31, 2021				153,950,895
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting standards update	Accounting Standards Update 2020-06 [Member]
Issuance of common stock for cash	$ 292,155			$ 5	292,150
Issuance of common stock for cash (in shares)				50,620,577
Exercise of stock options	829				829
Exercise of stock options (in shares)				616,304
Net loss	(561,919)
Exercise of common stock warrants (in shares)				540,541
Exercise of common stock warrants	10,249				10,249
Delivery of common stock underlying restricted stock units (in shares)				1,956,231
Issuance of restricted stock (in shares)				2,000,000
Stock-based compensation	65,518				65,518
Foreign currency translation adjustment	(767)									(767)
Net loss attributable to non-controlling interest	442										442
Net loss attributable to common shareholders	(561,477)							(561,477)
Ending balance at Dec. 31, 2022	401,682		$ 0	$ 21	1,972,006		$ 0	(1,558,088)		(595)	(11,662)
Treasury stock, ending balance (in shares) at Dec. 31, 2022							0
Preferred stock, ending balance (in shares) at Dec. 31, 2022			0
Common stock, ending balance (in shares) at Dec. 31, 2022				209,684,548
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for cash	$ 116,889			$ 8	116,881
Issuance of common stock for cash (in shares)				81,694,729
Exercise of stock options (in shares)	339,842			3,729,918
Cancellation of escrow shares in connection with Edisn acquisition (in shares)				(12,595)
Cancellation of escrow shares in connection with Edisn acquisition	$ (344)				(344)
Issuance of restricted stock	4,199			$ 1	4,198
Net loss	(287,917)
Exercise of common stock warrants (in shares)				339,842
Exercise of common stock warrants	373				373
Issuance of restricted stock (in shares)				3,778,718
Stock-based compensation	44,620				44,620
Molotov non-controlling interest	(499)				(864)					(9)	374
Foreign currency translation adjustment	4,822									4,822
Net loss attributable to non-controlling interest	463										463
Net loss attributable to common shareholders	(287,454)							(287,454)
Ending balance at Dec. 31, 2023	$ 283,825		$ 0	$ 30	$ 2,136,870		$ 0	$ (1,845,542)		$ 4,218	$ (11,751)
Treasury stock, ending balance (in shares) at Dec. 31, 2023							0
Preferred stock, ending balance (in shares) at Dec. 31, 2023			0
Common stock, ending balance (in shares) at Dec. 31, 2023				299,215,160